Literature DB >> 17064037

Structure reassignment and synthesis of Jenamidines A1/A2, synthesis of (+)-NP25302, and formal synthesis of SB-311009 analogues.

Jeremy R Duvall1, Fanghui Wu, Barry B Snider.   

Abstract

The proposed structures of jenamidines A, B, and C (1-3) were revised to jenamidines A1/A2, B1/B2, and C (8-10). Jenamidines A1/A2 (8) were synthesized from activated proline derivative 43 by conversion to 26 in two steps and 50% overall yield. Acylation of 26 with acid chloride 38d gave 39d, which was deprotected with TFA and then mild base to give 8 in 45% yield from 26. (-)-trans-2,5-Dimethylproline ethyl ester (49) was prepared by the enantioselective Michael reaction of ethyl 2-nitropropionate (51) and methyl vinyl ketone (50) using modified dihydroquinine 60 as the catalyst. Further elaboration converted 49 to natural (+)-NP25302 (12). A Wittig reaction of proline NCA (76) with ylide 79 gave 72 as a 9/1 E/Z mixture in 27% yield, completing a one-step formal synthesis of SB-311009 analogues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064037      PMCID: PMC2528249          DOI: 10.1021/jo061650+

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  21 in total

1.  SB-253514 and analogues; novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity.

Authors:  J Thirkettle; E Alvarez; H Boyd; M Brown; E Diez; J Hueso; S Elson; M Fulston; C Gershater; M L Morata; P Perez; S Ready; J M Sanchez-Puelles; R Sheridan; A Stefanska; S Warr
Journal:  J Antibiot (Tokyo)       Date:  2000-07       Impact factor: 2.649

2.  SB-253514 and analogues; novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. III. Biotransformation using naringinase.

Authors:  J Thirkettle
Journal:  J Antibiot (Tokyo)       Date:  2000-07       Impact factor: 2.649

3.  Construction of quaternary stereocenters by efficient and practical conjugate additions to alpha,beta-unsaturated ketones with a chiral organic catalyst.

Authors:  Fanghui Wu; Hongming Li; Ran Hong; Li Deng
Journal:  Angew Chem Int Ed Engl       Date:  2006-01-30       Impact factor: 15.336

4.  Combination detergent/MALDI matrix: functional cleavable detergents for mass spectrometry.

Authors:  Jeremy L Norris; Ned A Porter; Richard M Caprioli
Journal:  Anal Chem       Date:  2005-08-01       Impact factor: 6.986

5.  Efficient synthesis of enantiopure pyrrolizidinone amino acid.

Authors:  Evelyne Dietrich; William D Lubell
Journal:  J Org Chem       Date:  2003-09-05       Impact factor: 4.354

6.  Derivatives of 1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione as anxiolytic agents.

Authors:  W B Wright; H J Brabander; E N Greenblatt; I P Day; R A Hardy
Journal:  J Med Chem       Date:  1978-10       Impact factor: 7.446

7.  Natural product derived inhibitors of lipoprotein associated phospholipase A2, synthesis and activity of analogues of SB-253514.

Authors:  I L Pinto; H F Boyd; D M Hickey
Journal:  Bioorg Med Chem Lett       Date:  2000-09-04       Impact factor: 2.823

8.  Organocatalytic asymmetric conjugate addition of nitroalkanes to alpha,beta-unsaturated enones using novel imidazoline catalysts.

Authors:  Nis Halland; Rita G Hazell; Karl Anker Jørgensen
Journal:  J Org Chem       Date:  2002-11-29       Impact factor: 4.354

9.  Jenamidines A to C: unusual alkaloids from Streptomyces sp. with specific antiproliferative properties obtained by chemical screening.

Authors:  Jin-Feng Hu; Dirk Wunderlich; Ralf Thiericke; Hans-Martin Dahse; Susanne Grabley; Xiao-Zhang Feng; Isabel Sattler
Journal:  J Antibiot (Tokyo)       Date:  2003-09       Impact factor: 2.649

10.  Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors.

Authors:  Robert M Rydzewski; Clifford Bryant; Renata Oballa; Gregg Wesolowski; Sevgi B Rodan; Kathryn E Bass; Darren H Wong
Journal:  Bioorg Med Chem       Date:  2002-10       Impact factor: 3.641

View more
  8 in total

Review 1.  Controlled microwave heating in modern organic synthesis: highlights from the 2004-2008 literature.

Authors:  C Oliver Kappe; Doris Dallinger
Journal:  Mol Divers       Date:  2009-04-21       Impact factor: 2.943

2.  Stereoselective Synthesis of Quaternary Proline Analogues.

Authors:  M Isabel Calaza; Carlos Cativiela
Journal:  European J Org Chem       Date:  2008

3.  Spithioneines A and B, Two New Bohemamine Derivatives Possessing Ergothioneine Moiety from a Marine-Derived Streptomyces spinoverrucosus.

Authors:  Peng Fu; John B MacMillan
Journal:  Org Lett       Date:  2015-05-29       Impact factor: 6.005

4.  1,3-Oxazin-6-one Derivatives and Bohemamine-Type Pyrrolizidine Alkaloids from a Marine-Derived Streptomyces spinoverrucosus.

Authors:  Peng Fu; Scott La; John B MacMillan
Journal:  J Nat Prod       Date:  2015-10-21       Impact factor: 4.050

5.  Genomic scanning enabling discovery of a new antibacterial bicyclic carbamate-containing alkaloid.

Authors:  Qing Fang; Linrui Wu; Caroline Urwald; Morgane Mugat; Shan Wang; Kwaku Kyeremeh; Carol Philips; Samantha Law; Yongjun Zhou; Hai Deng
Journal:  Synth Syst Biotechnol       Date:  2021-01-20

6.  Synthesis of legonmycins A and B, C(7a)-hydroxylated bacterial pyrrolizidines.

Authors:  Wilfred J M Lewis; David M Shaw; Jeremy Robertson
Journal:  Beilstein J Org Chem       Date:  2021-02-02       Impact factor: 2.883

7.  Fe3O4@SiO2 nanoparticle supported ionic liquid for green synthesis of antibacterially active 1-carbamoyl-1-phenylureas in water.

Authors:  Mahmoud Nasrollahzadeh; Zahra Issaabadi; S Mohammad Sajadi
Journal:  RSC Adv       Date:  2018-08-02       Impact factor: 3.361

8.  Simple and efficient synthesis of bicyclic enol-carbamates: access to brabantamides and their analogues.

Authors:  Ondrej Záborský; Ľudmila Petrovičová; Jana Doháňošová; Ján Moncol; Róbert Fischer
Journal:  RSC Adv       Date:  2020-02-13       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.